This inventor holds 2 USPTO granted patents. Top assignee: Nitromed, Inc.. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: Innovations by Ramani R Bandarage
Introduction
Ramani R Bandarage is an accomplished inventor based in Newton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target cyclooxygenase-2 (COX-2) inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various inflammatory conditions.
Latest Patents
His latest patents focus on "Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use." These inventions describe innovative nitrosated and/or nitrosylated COX-2 inhibitors and compositions that include at least one of these inhibitors. The patents also detail methods for treating inflammation, pain, and fever, as well as improving the gastrointestinal properties of COX-2 inhibitors. Additionally, they provide kits and methods for facilitating wound healing and preventing renal toxicity.
Career Highlights
Ramani R Bandarage is associated with Nitromed, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic outcomes for patients suffering from conditions related to elevated levels of COX-2.
Collaborations
Throughout his career, Bandarage has collaborated with notable colleagues, including David S Garvey and L Gordon Letts. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
Ramani R Bandarage's contributions to the field of pharmaceuticals, particularly through his patents on COX-2 inhibitors, demonstrate his dedication to advancing medical science. His work has the potential to significantly improve treatment options for patients with inflammatory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
